PTC Therapeutics publie ses résultats sur une base trimestrielle. Ces rapports trimestriels sur les résultats donnent aux investisseurs un aperçu des résultats financiers d'une entreprise sur une période de 3 mois. Les rapports sur les résultats incluent presque toujours les résultats du BPA et du chiffre d'affaires.
Analysez l'historique des bénéfices de PTC Therapeutics en utilisant des tris et des filtres avancés.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
PTCT | PTC Therapeutics | -$1.39 | -$1.14 | $0.20 | 117.54% | $196.79M | $175.55M | $211.01M | 20.20% | 11/04/2025 | |
PTCT | PTC Therapeutics | -$1.29 | -$1.07 | -$0.83 | 22.43% | $186.70M | $172.68M | $178.88M | 3.59% | 08/07/2025 | |
PTCT | PTC Therapeutics | -$1.20 | -$0.70 | $10.04 | 1534.29% | $210.12M | $372.61M | $1.18B | 215.61% | 05/06/2025 | |
PTCT | PTC Therapeutics | -$0.24 | -$0.65 | -$0.85 | -30.77% | $307.06M | $248.99M | $213.17M | -14.39% | 02/27/2025 | |
PTCT | PTC Therapeutics | -$1.76 | -$1.44 | -$1.39 | 3.47% | $196.58M | $172.65M | $196.79M | 13.98% | 11/07/2024 | |
PTCT | PTC Therapeutics | -$1.48 | -$1.05 | -$1.29 | -22.86% | $213.81M | $185.87M | $186.70M | 0.45% | 08/08/2024 | |
PTCT | PTC Therapeutics | -$1.88 | -$1.24 | -$1.20 | 3.23% | $220.38M | $169.70M | $210.12M | 23.82% | 04/25/2024 | |
PTCT | PTC Therapeutics | -$1.89 | $0.50 | -$0.24 | -148.00% | $167.41M | $321.29M | $307.06M | -4.43% | 02/29/2024 | |
PTCT | PTC Therapeutics | -$1.53 | -$1.17 | -$1.76 | -50.43% | $217.13M | $210.19M | $196.58M | -6.48% | 10/26/2023 | |
PTCT | PTC Therapeutics | -$2.13 | -$1.58 | -$1.48 | 6.33% | $165.53M | $213.95M | $213.81M | -0.07% | 08/03/2023 | |
PTCT | PTC Therapeutics | -$1.78 | -$1.39 | -$1.88 | -35.25% | $148.74M | $182.62M | $220.38M | 20.68% | 04/27/2023 | |
PTCT | PTC Therapeutics | -$2.03 | -$1.59 | -$1.89 | -18.87% | $165.23M | $189.14M | $167.41M | -11.49% | 02/21/2023 | |
PTCT | PTC Therapeutics | -$1.89 | -$1.19 | -$1.53 | -28.57% | $138.74M | $186.90M | $217.13M | 16.17% | 10/27/2022 | |
PTCT | PTC Therapeutics | -$1.68 | -$1.33 | -$2.13 | -60.15% | $116.68M | $162.09M | $165.53M | 2.12% | 08/04/2022 | |
PTCT | PTC Therapeutics | -$1.83 | -$1.51 | -$1.78 | -17.88% | $117.94M | $147.06M | $148.74M | 1.14% | 05/03/2022 | |
PTCT | PTC Therapeutics | -$1.08 | -$1.64 | -$2.03 | -23.78% | $118.86M | $150.83M | $165.23M | 9.55% | 02/22/2022 | |
PTCT | PTC Therapeutics | -$1.03 | -$1.40 | -$1.89 | -35.00% | $118.40M | $126.44M | $138.74M | 9.73% | 10/28/2021 | |
PTCT | PTC Therapeutics | -$2.62 | -$1.82 | -$1.68 | 7.69% | $75.24M | $110.50M | $116.68M | 5.59% | 07/29/2021 | |
PTCT | PTC Therapeutics | -$1.81 | -$1.51 | -$1.83 | -21.19% | $68.26M | $98.80M | $117.94M | 19.37% | 05/04/2021 | |
PTCT | PTC Therapeutics | -$1.37 | -$0.94 | -$1.08 | -14.89% | $96.46M | $111.36M | $118.86M | 6.74% | 02/25/2021 |
| Trimestre Fiscal | Date de Déclaration | BPA Réel | BPA Estimé | Surprendre % |
|---|---|---|---|---|
| Q3 | 2025-11-04 | $0.20 | $-1.14 | 117.5 % |
| Q2 | 2025-08-07 | $-0.83 | $-1.07 | 22.4 % |
| Q1 | 2025-05-06 | $10.04 | $-0.70 | 1534.3 % |
| Q4 | 2025-02-27 | $-0.85 | $-0.65 | -30.8 % |
| Trimestre Fiscal | Date de Déclaration | Revenu Réel | Revenu Estimé | Surprendre % |
|---|---|---|---|---|
| Q3 | 2025-11-04 | $211.01M | $175.55M | 20.2 % |
| Q2 | 2025-08-07 | $178.88M | $172.68M | 3.59 % |
| Q1 | 2025-05-06 | $1.18B | $372.61M | 215.6 % |
| Q4 | 2025-02-27 | $213.17M | $248.99M | -14.4 % |
PTC Therapeutics (PTCT) n'a pas de rapports de bénéfices à venir prévus. Les derniers bénéfices rapportés étaient pour Q3 le novembre 4, 2025.
PTC Therapeutics (PTCT) n'a pas de rapports de bénéfices à venir prévus. Les derniers bénéfices rapportés étaient pour Q3 le novembre 4, 2025 et le BPA réel était de $0.20, ce qui dépassé l'estimation de $-1.14.
PTC Therapeutics (PTCT) n'a pas de rapports de bénéfices à venir prévus. Les derniers bénéfices rapportés étaient pour Q3 le novembre 4, 2025 et le chiffre d'affaires réel était de $211M, ce qui dépassé l'estimation de $175.5M.
Parcourir estimations des bénéfices, EPS et chiffre d'affaires sur toutes les actions.